App-based sleep therapy for older adults with chronic insomnia
Tests a smart-device sleep therapy for insomnia in older adults.
Key facts
- Who runs it
- Proactive Life Inc
- Where
- New York, United StatesSee the site
- Trial code
- Registry title
- Deep Sleep in Older Adults
- Status
- Recruiting
- Phase
- Phase 2
- People taking part
- 180 people, planned
- Started
- 30 Sept 2026
- Expected to end
- 30 Aug 2027
- Type of study
- Interventional, 3 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- SleepSpaceRx CBT-I-IoT-AI
- SleepEZ CBTi
- Sleep Hygiene IoT
- Record updated
- 20 October 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 55 or older who have long-lasting trouble sleeping (insomnia). They must live independently and have WIFI at home. The trial compares three phone-based sleep programs.
- Age
- 55 years and older
- Sex
- All
- Disease stage
- Insomnia Severity Index score of 15 or more (moderate to severe). If recruitment is slow, a score of 11 or more may be accepted. Trouble sleeping happens at least 3 nights a week for 3+ months and causes problems during the day.
- Earlier treatment
- You cannot have had psychotherapy for insomnia (such as CBT-I) now or in the past 1 year, or ever a full course of CBT-I. You cannot have started any psychological treatment in the last 3 months. You cannot have used the SleepSpace software before. People must keep any current sleep medicine from their doctor and not start new sleep treatments during the trial.
Main reasons for not taking part
- Illegal drug use in the past month (marijuana is allowed)
- Serious mental health disorder, such as psychosis, bipolar depression, severe major depression, suicide risk or dementia
- Living with someone who is or was in this study
- Very irregular schedule, such as shift work
- Medical conditions made worse by limiting sleep, or major surgery planned during the trial
The registry criteria, word for word
Show all 19 criteriaShow less
Who can take part
- Fluent English speaker and reader
- Capable of providing one's own informed consent; As determined by validated, abbreviated phone-based remote Montreal Cognitive Assessment (MoCA) testing score of ≥18, which is the score that separates Mild Cognitive Impairment (MCI) from Alzheimer's Disease and Related Dementia (ADRD)
- Age 55+ years old (inclusive) at enrollment. a. As self-reported on screening survey and later verified in video appointment (e.g. Zoom Health)
- If residing in a community residence (such as a retirement community) in which a Medical Director designates living status categories, then the participant must be Independent Living status (or equivalent); As self-reported on screening survey
- Insomnia Severity Index score ≥15 (i.e., at least "clinical insomnia," that is "moderate-to-severe") - but if recruitment is slow then the investigators will recruit with ISI score ≥11 "mild-to-severe"); As self-reported on the ISI screening survey
- Willing to refrain from initiating new therapeutic interventions (e.g. medication; behavioral) that are not a part of this study protocol for issues pertaining to sleep for the duration of study participation; By self-report
- Willing to maintain any existing physician-directed pharmacologic intervention for issues pertaining to sleep for the duration of study participation; By self-report
- Has a residence with WIFI; By self-report
- Normal hearing with or without a hearing aid; By self-report
- Difficulty falling asleep, staying asleep, or waking too early, occurring at least 3 nights/week for 3+months, causing significant daytime distress/impairment (e.g., fatigue, poor focus, mood issues), despite adequate sleep opportunity, and not better explained by another sleep disorder or substance; By Sleep Condition Indicator [SCI]
Who cannot take part
- Illicit drug use in the past month (except for marijuana because it is legal in many States, and the investigators are recruiting nationwide); As self-reported on screening survey. Marijuana usage will be tracked via self-report and examined as a moderator
- Currently or recent engaged (past 1-year) in evidence-based psychotherapy for Insomnia (e.g., CBTi), in addition to ever receiving a full course of CBTi:; By self-report
- Cohabitating with a current or previous participant in this study; This criterion is to avoid cross-contamination of study condition awareness, if two cohabitating individuals are randomized into different study arms
- Previous exposure to the SleepSpace software
- Planned major surgery during the trial
- Diagnosed serious mental health disorder; Specifically, psychosis or bipolar depression, severe major depression, moderate to high risk of suicide, dementia; As self-reported on screening survey
- A highly irregular schedule (e.g. shift work) that would prevent adoption of intervention strategies, as evaluated through the Shift Work Disorder Index
- Medical conditions that are exacerbated by sleep restriction
- Initiation of any psychological treatment in the last 3-months
Where in United States
- SleepSpaceNew York, United StatesContact: Daniel Gartenberg, PhDTaking people
About the trial
What the trial wants to find out
This double blind randomized clinical trial on older independent-living healthy individuals with symptoms of insomnia will harness Cognitive Behavioral Therapy for Insomnia (CBT-I) and augment it with ambulatory data collection devices, personalized digital content, and smart sound and light cues (CBT-I +Internet of Things [IoT]+Artificial Intelligence [AI]). With this approach, the investigators aim to overcome many of the limitations that CBT-I in the clinic faces: the investigators can implement it in ambulatory settings while providing increased (remote) accessibility to therapy. The investigators will compare the CBT-I +IoT+AI to active controls that also integrate with smart phone devices, including SleepEZ, which is also based on CBT-I, and sleep hygiene education. These active controls will help determine whether CBT-I +IoT+AI is effective at treating insomnia based on the Insomnia Severity Index (ISI) (primary outcome), sleep metrics (secondary outcome), cognitive performance (secondary outcome), and additional outcomes like therapeutic adherence and other mental health assessments. Participants will be asked to track sleep with wearable and nearable devices, complete surveys, and complete cognitive assessments.
The 3 groups in the trial
- SleepSpaceRx CBT-I-IoT-AITreatment being tested
Participants randomized to this study arm will experience an attempted enhancement of standard video based digital CBT-I, that is facilitated with electronic device-based interventions (Internet of Things) and artificial intelligence (AI) customizations of content. Noninvasive ambulatory worn + bedside devices deliver real-time feedback of objective data to the participant on an application interface and this data is used to customize the software and promote healthy sleep routines. In addition, daily animated videos are customized to the users' challenges. Subjective data collected using the application are available live to the participant, when appropriate. Environmental cues and notifications are programmed into IoT devices to remind patients of their behavioral prescription and to create a living-space environment that is conducive to effective therapy. This will include smart lights and sounds that cue the participant.
- Sleep-EZ CBT-I Based SolutionExisting treatment, for comparison
Participants randomized to this study arm will experience standard digital-based CBT-I that is delivered via the Path to Better Sleep program called SleepEZ that was created by Veteran Affairs (VA). The program will be administered within the SleepSpace software, which will be used to track adherence and deliver sham interventions. Users will have access to a pared-down version of the SleepSpace electronic application that enables them to track sleep in a sleep diary, access the content found in SleepEZ, and integrate with smart light bulbs and sounds to receive certain sound and light interventions. For example, the lights will brighten during the users expected circadian dip.
Treatment: SleepEZ CBTi
- Sleep Hygiene + IoTExisting treatment, for comparison
Participants randomized to this study arm will experience sleep hygiene education and training, a component of CBT-I, which will also occur within the SleepSpace software to ensure all participants receive the same software platform and adherence is tracked uniformly across solutions. Users will have access to a version of our electronic application that enables them to track sleep in a sleep diary, access the animated Sleep Hygiene content created in the same way as the videos in the CBTi-IoT-AI condition, and integrate with smart light bulbs and sounds to receive certain sound and light interventions.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- An Internet of Things Automated Cognitive Behavioral Therapy for Insomnia That Improves Cognition in Older Adults
- Plain-language title
- App-based sleep therapy for older adults with chronic insomniaGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 20 October 2026